Award of real-time analyzers' army sbir 19.d phase II medical r & d contract from proposal A2-7989 for "immunosuppressant drug monitor"

Ended Definitive Contract Awarded Last action

Contract number
W81XWH20C0037
Awardee
Awarding agency
Obligated
$999,997

Award facts

Opportunity
  • HQ003419RODAB Solicitation number
Contract value 100% obligated
$999,997.22 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Middletown, CT 06457, USA
Research
SBIR Program Phase II Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00006 · Per section 711 of the 2019 ndaa, usamraa transferred to DHA 10/1/2022. Also, NCE to the award of RTA's army sbir phase II medical r & d contract for… $0
Supplemental Agreement for work within scope P00005 · No-cost extension to the award of RTA's army sbir phase II medical r & d contract for "immunosuppressant drug monitor" $0
Other Administrative Action P00004 · COR change to the award of RTA's army sbir phase II medical r & d contract for "immunosuppressant drug monitor" $0
Supplemental Agreement for work within scope P00003 · Incremental funding and clause updates for the award of RTA's army sbir phase II medical r & d contract for "immunosuppressant drug monitor" $499,999
Supplemental Agreement for work within scope P00002 · COR change and clause and language updates to the award of RTA's army sbir phase II medical r & d contract for "immunosuppressant drug monitor" $0
Supplemental Agreement for work within scope P00001 · Clause additions and language update to RTA's award of army sbir phase II medical r & d contract for "immunosuppressant drug monitor" $0
Original award $499,999

About this award

Real-Time Analyzers Inc. was awarded a definitive contract valued at approximately $1 million by the Department of the Army Medical Command to support research and development efforts under Phase II of the Small Business Innovation Research program. The contract is for work originating from proposal A2-7989 involving development of an immunosuppressant drug monitoring solution. Research will be conducted in Middletown, Connecticut over a three-year period concluding in April 2023. The firm fixed price contract has been set aside for total small businesses. No major subcontractors were identified. The award provides continued support for the Army's medical R&D programs through the SBIR vehicle and efforts to advance monitoring of drug therapies for patients.

Quick answers

Who was awarded contract W81XWH20C0037?

W81XWH20C0037 was awarded to Real-Time Analyzers Inc. by Medical Command (Department of the Army) on June 3, 2020.

How much is contract W81XWH20C0037 worth?

The government has obligated $999,997 on W81XWH20C0037.

Was contract W81XWH20C0037 competed?

The extent of competition for W81XWH20C0037 was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award